BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 12053601)

  • 21. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucolytics in cystic fibrosis.
    Henke MO; Ratjen F
    Paediatr Respir Rev; 2007 Mar; 8(1):24-9. PubMed ID: 17419975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
    Sadowska AM
    Ther Adv Respir Dis; 2012 Jun; 6(3):127-35. PubMed ID: 22361928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-acetylcysteine.
    Altern Med Rev; 2000 Oct; 5(5):467-71. PubMed ID: 11056417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine.
    Santus P; Corsico A; Solidoro P; Braido F; Di Marco F; Scichilone N
    COPD; 2014 Dec; 11(6):705-17. PubMed ID: 24787454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic possibilities in chronic non-specific respiratory tract diseases. 1. Modification of secretion, inhalation- and respiration therapy, therapy of bronchial obstruction].
    Löllgen H; Löllgen-Horres I; von Nieding G
    Fortschr Med; 1976 Aug; 94(24):1276-84. PubMed ID: 786833
    [No Abstract]   [Full Text] [Related]  

  • 28. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Respir Care; 2002 Jul; 47(7):818-22. PubMed ID: 12088552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of mucolytic preparations (Mucosolvan) in selected diseases of the upper respiratory tract. Part II].
    Szmeja Z; Golusiński W; Mielcarek-Kuchta D; Laczkowska-Przybylska J
    Otolaryngol Pol; 1997; 51(5):480-6. PubMed ID: 9557050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing exacerbations of chronic bronchitis and COPD.
    Ekberg-Jansson A; Larsson S; Löfdahl CG
    BMJ; 2001 May; 322(7297):1259-61. PubMed ID: 11375214
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inhalation therapy from the modern point of view].
    Stadeler HJ
    Schweiz Rundsch Med Prax; 1971 Nov; 60(45):1509-12. PubMed ID: 4946731
    [No Abstract]   [Full Text] [Related]  

  • 32. Possibility of interaction among antibiotics and mucolytics in children.
    Principi N; Zavattini G; Daniotti S
    Int J Clin Pharmacol Res; 1986; 6(5):369-72. PubMed ID: 3781700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-inflammatory efficacy of N-acetylcysteine and therapeutic usefulness].
    Gillissen A
    Pneumologie; 2011 Sep; 65(9):549-57. PubMed ID: 21761386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Medical maintenance treatment of chronic obstructive pulmonary disease (COPD)].
    Kerstjens HA; Postma DS
    Ned Tijdschr Geneeskd; 2002 Aug; 146(35):1631-5. PubMed ID: 12233157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of ambroxol in treatment of bronchial asthma and spastic bronchitis].
    Siergiejko Z; Obrzut D; Rogalewska A
    Pol Tyg Lek; 1991 May 27-Jun 3; 46(22-23):424-7. PubMed ID: 1669082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
    Baldini G; Gucci M; Tarò D; Memmini C
    Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of expectorants.
    Hirsch SR
    Wis Med J; 1971 May; 70(5):153-6. PubMed ID: 4941901
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy.
    Gillissen A; Nowak D
    Respir Med; 1998 Apr; 92(4):609-23. PubMed ID: 9659525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic activity of an association of a mucolytic drug and a bronchodilator agent in the treatment of respiratory inflammations].
    Boselli G
    Minerva Med; 1973 Nov; 64(79):4128-37. PubMed ID: 4765427
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluating the efficacy of mucoactive aerosol therapy.
    Fuloria M; Rubin BK
    Respir Care; 2000 Jul; 45(7):868-73. PubMed ID: 10926385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.